table of content
1 Introduction to Research & Analysis Reports
1.1 Psychedelic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psychedelic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Psychedelic Drugs Overall Market Size
2.1 Global Psychedelic Drugs Market Size: 2022 VS 2030
2.2 Global Psychedelic Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Psychedelic Drugs Players in Global Market
3.2 Top Global Psychedelic Drugs Companies Ranked by Revenue
3.3 Global Psychedelic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Psychedelic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Psychedelic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Psychedelic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Psychedelic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Psychedelic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Psychedelic Drugs Market Size Markets, 2022 & 2030
4.1.2 Psilocybin
4.1.3 LSD
4.1.4 MDMA
4.1.5 DMT
4.1.6 Ketamine
4.1.7 Others
4.2 By Type - Global Psychedelic Drugs Revenue & Forecasts
4.2.1 By Type - Global Psychedelic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Psychedelic Drugs Revenue, 2024-2030
4.2.3 By Type - Global Psychedelic Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Psychedelic Drugs Market Size, 2022 & 2030
5.1.2 Depressive Disorders
5.1.3 Post-Traumatic Stress Disorders
5.1.4 Substance Abuse Disorders
5.1.5 Obsessive Compulsive Disorders
5.1.6 Others
5.2 By Application - Global Psychedelic Drugs Revenue & Forecasts
5.2.1 By Application - Global Psychedelic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Psychedelic Drugs Revenue, 2024-2030
5.2.3 By Application - Global Psychedelic Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Psychedelic Drugs Market Size, 2022 & 2030
6.2 By Region - Global Psychedelic Drugs Revenue & Forecasts
6.2.1 By Region - Global Psychedelic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Psychedelic Drugs Revenue, 2024-2030
6.2.3 By Region - Global Psychedelic Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Psychedelic Drugs Revenue, 2018-2030
6.3.2 US Psychedelic Drugs Market Size, 2018-2030
6.3.3 Canada Psychedelic Drugs Market Size, 2018-2030
6.3.4 Mexico Psychedelic Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Psychedelic Drugs Revenue, 2018-2030
6.4.2 Germany Psychedelic Drugs Market Size, 2018-2030
6.4.3 France Psychedelic Drugs Market Size, 2018-2030
6.4.4 U.K. Psychedelic Drugs Market Size, 2018-2030
6.4.5 Italy Psychedelic Drugs Market Size, 2018-2030
6.4.6 Russia Psychedelic Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Psychedelic Drugs Market Size, 2018-2030
6.4.8 Benelux Psychedelic Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Psychedelic Drugs Revenue, 2018-2030
6.5.2 China Psychedelic Drugs Market Size, 2018-2030
6.5.3 Japan Psychedelic Drugs Market Size, 2018-2030
6.5.4 South Korea Psychedelic Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Psychedelic Drugs Market Size, 2018-2030
6.5.6 India Psychedelic Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Psychedelic Drugs Revenue, 2018-2030
6.6.2 Brazil Psychedelic Drugs Market Size, 2018-2030
6.6.3 Argentina Psychedelic Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Psychedelic Drugs Revenue, 2018-2030
6.7.2 Turkey Psychedelic Drugs Market Size, 2018-2030
6.7.3 Israel Psychedelic Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Psychedelic Drugs Market Size, 2018-2030
6.7.5 UAE Psychedelic Drugs Market Size, 2018-2030
7 Psychedelic Drugs Companies Profiles
7.1 COMPASS Pathways PLC
7.1.1 COMPASS Pathways PLC Company Summary
7.1.2 COMPASS Pathways PLC Business Overview
7.1.3 COMPASS Pathways PLC Psychedelic Drugs Major Product Offerings
7.1.4 COMPASS Pathways PLC Psychedelic Drugs Revenue in Global Market (2018-2023)
7.1.5 COMPASS Pathways PLC Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Psychedelic Drugs Major Product Offerings
7.2.4 Pfizer Psychedelic Drugs Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Psychedelic Drugs Major Product Offerings
7.3.4 Eli Lilly Psychedelic Drugs Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Psychedelic Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Psychedelic Drugs Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Cybin Inc
7.5.1 Cybin Inc Company Summary
7.5.2 Cybin Inc Business Overview
7.5.3 Cybin Inc Psychedelic Drugs Major Product Offerings
7.5.4 Cybin Inc Psychedelic Drugs Revenue in Global Market (2018-2023)
7.5.5 Cybin Inc Key News & Latest Developments
7.6 Field Trip Health
7.6.1 Field Trip Health Company Summary
7.6.2 Field Trip Health Business Overview
7.6.3 Field Trip Health Psychedelic Drugs Major Product Offerings
7.6.4 Field Trip Health Psychedelic Drugs Revenue in Global Market (2018-2023)
7.6.5 Field Trip Health Key News & Latest Developments
7.7 ATAI Life Sciences
7.7.1 ATAI Life Sciences Company Summary
7.7.2 ATAI Life Sciences Business Overview
7.7.3 ATAI Life Sciences Psychedelic Drugs Major Product Offerings
7.7.4 ATAI Life Sciences Psychedelic Drugs Revenue in Global Market (2018-2023)
7.7.5 ATAI Life Sciences Key News & Latest Developments
7.8 NUMINUS WELLNESS
7.8.1 NUMINUS WELLNESS Company Summary
7.8.2 NUMINUS WELLNESS Business Overview
7.8.3 NUMINUS WELLNESS Psychedelic Drugs Major Product Offerings
7.8.4 NUMINUS WELLNESS Psychedelic Drugs Revenue in Global Market (2018-2023)
7.8.5 NUMINUS WELLNESS Key News & Latest Developments
7.9 MindMed
7.9.1 MindMed Company Summary
7.9.2 MindMed Business Overview
7.9.3 MindMed Psychedelic Drugs Major Product Offerings
7.9.4 MindMed Psychedelic Drugs Revenue in Global Market (2018-2023)
7.9.5 MindMed Key News & Latest Developments
7.10 HAVN Life Sciences
7.10.1 HAVN Life Sciences Company Summary
7.10.2 HAVN Life Sciences Business Overview
7.10.3 HAVN Life Sciences Psychedelic Drugs Major Product Offerings
7.10.4 HAVN Life Sciences Psychedelic Drugs Revenue in Global Market (2018-2023)
7.10.5 HAVN Life Sciences Key News & Latest Developments
7.11 Seelos Therapeutics
7.11.1 Seelos Therapeutics Company Summary
7.11.2 Seelos Therapeutics Business Overview
7.11.3 Seelos Therapeutics Psychedelic Drugs Major Product Offerings
7.11.4 Seelos Therapeutics Psychedelic Drugs Revenue in Global Market (2018-2023)
7.11.5 Seelos Therapeutics Key News & Latest Developments
7.12 Jannsen
7.12.1 Jannsen Company Summary
7.12.2 Jannsen Business Overview
7.12.3 Jannsen Psychedelic Drugs Major Product Offerings
7.12.4 Jannsen Psychedelic Drugs Revenue in Global Market (2018-2023)
7.12.5 Jannsen Key News & Latest Developments
7.13 Acadia Pharmaceuticals
7.13.1 Acadia Pharmaceuticals Company Summary
7.13.2 Acadia Pharmaceuticals Business Overview
7.13.3 Acadia Pharmaceuticals Psychedelic Drugs Major Product Offerings
7.13.4 Acadia Pharmaceuticals Psychedelic Drugs Revenue in Global Market (2018-2023)
7.13.5 Acadia Pharmaceuticals Key News & Latest Developments
7.14 Intellipharmaceutics
7.14.1 Intellipharmaceutics Company Summary
7.14.2 Intellipharmaceutics Business Overview
7.14.3 Intellipharmaceutics Psychedelic Drugs Major Product Offerings
7.14.4 Intellipharmaceutics Psychedelic Drugs Revenue in Global Market (2018-2023)
7.14.5 Intellipharmaceutics Key News & Latest Developments
7.15 Revive Therapeutics
7.15.1 Revive Therapeutics Company Summary
7.15.2 Revive Therapeutics Business Overview
7.15.3 Revive Therapeutics Psychedelic Drugs Major Product Offerings
7.15.4 Revive Therapeutics Psychedelic Drugs Revenue in Global Market (2018-2023)
7.15.5 Revive Therapeutics Key News & Latest Developments
7.16 Mydecine Innovations Group
7.16.1 Mydecine Innovations Group Company Summary
7.16.2 Mydecine Innovations Group Business Overview
7.16.3 Mydecine Innovations Group Psychedelic Drugs Major Product Offerings
7.16.4 Mydecine Innovations Group Psychedelic Drugs Revenue in Global Market (2018-2023)
7.16.5 Mydecine Innovations Group Key News & Latest Developments
7.17 Red Light Holland
7.17.1 Red Light Holland Company Summary
7.17.2 Red Light Holland Business Overview
7.17.3 Red Light Holland Psychedelic Drugs Major Product Offerings
7.17.4 Red Light Holland Psychedelic Drugs Revenue in Global Market (2018-2023)
7.17.5 Red Light Holland Key News & Latest Developments
7.18 Braxia Scientific
7.18.1 Braxia Scientific Company Summary
7.18.2 Braxia Scientific Business Overview
7.18.3 Braxia Scientific Psychedelic Drugs Major Product Offerings
7.18.4 Braxia Scientific Psychedelic Drugs Revenue in Global Market (2018-2023)
7.18.5 Braxia Scientific Key News & Latest Developments
7.19 Mind Cure Health
7.19.1 Mind Cure Health Company Summary
7.19.2 Mind Cure Health Business Overview
7.19.3 Mind Cure Health Psychedelic Drugs Major Product Offerings
7.19.4 Mind Cure Health Psychedelic Drugs Revenue in Global Market (2018-2023)
7.19.5 Mind Cure Health Key News & Latest Developments
7.20 Entheon Biomedical
7.20.1 Entheon Biomedical Company Summary
7.20.2 Entheon Biomedical Business Overview
7.20.3 Entheon Biomedical Psychedelic Drugs Major Product Offerings
7.20.4 Entheon Biomedical Psychedelic Drugs Revenue in Global Market (2018-2023)
7.20.5 Entheon Biomedical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
